Download presentation
Presentation is loading. Please wait.
Published by轨归 严 Modified over 5 years ago
1
Results of common femoral artery thromboendarterectomy evaluation of a traditional surgical management in the endovascular era Carola Marie Wieker, MD, Eva Schönefeld, MD, Nani Osada, DRM, Christina Lührs, MD, Roland Beneking, MD, Giovanni Torsello, MD, Dittmar Böckler, MD Journal of Vascular Surgery Volume 64, Issue 4, Pages (October 2016) DOI: /j.jvs Copyright © 2016 Society for Vascular Surgery Terms and Conditions
2
Fig 1 Kaplan-Meier estimates of overall primary patency (PP) examined by duplex imaging. Journal of Vascular Surgery , DOI: ( /j.jvs ) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
3
Fig 2 Kaplan-Meier estimates of overall secondary patency (SP) examined by duplex imaging. Journal of Vascular Surgery , DOI: ( /j.jvs ) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
4
Fig 3 Kaplan-Meier estimates of primary patency (PP) in patients with intermittent claudication (IC; blue line) vs those with critical limb (CL) ischemia (CLI; green line). P = .32 by χ2 test. Journal of Vascular Surgery , DOI: ( /j.jvs ) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
5
Fig 4 Kaplan-Meier estimates of primary patency (PP) for patients with hybrid procedures (blue line) vs those with isolated common femoral artery (CFA) endarterectomy (CFE; green line) without endovascular intervention. P = .69 by χ2 test. Journal of Vascular Surgery , DOI: ( /j.jvs ) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
6
Fig 5 Kaplan-Meier estimates of overall survival.
Journal of Vascular Surgery , DOI: ( /j.jvs ) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
7
Fig 6 Kaplan-Meier estimate of the survival of patients with intermittent claudication (IC; blue line) vs those with critical limb (CL) ischemia (CLI; green line). P < .001 by χ2 test. Journal of Vascular Surgery , DOI: ( /j.jvs ) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.